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Abstract
Introduction While epilepsy is a well-characterized disease,
the majority of emergency department (ED) visits for
“seizure” involve patients without known epilepsy. The
epidemiology of seizure presentations and national patterns
of management are unclear. The aim of this investigation
was to characterize ED visits for seizure in a large
representative US sample and investigate any potential
impact of race or ethnicity on management.
Methods Seizure visits from the National Hospital Ambula-
tory Medical Care Survey (NHAMCS) from 1993 to 2003
were analysed. Demographic factors associated with presen-
tation, neuroimaging and hospital admission in the USAwere
analysed using controlled multivariate logistic regression.
Results Seizure accounts for 1 million ED visits annually
[95% confidence interval (CI): 926,000–1,040,000], or 1%
of all ED visits in the USA. Visits were most common
among infants, at 8.0 per 1,000 population (95% CI: 6.0–
10.0), and children aged 1–5 years (7.4; 95% CI: 6.4–8.4).
Seizure was more likely among those with alcohol-related
visits [odds ratio (OR): 3.2; 95% CI: 2.7–3.9], males (OR:
1.4; 95% CI: 1.3–1.5) and Blacks (OR: 1.4; 95% CI: 1.3–
1.6). Neuroimaging was used less in Blacks than Whites
(OR: 0.6; 95% CI: 0.4–0.8) and less in Hispanics than non-
Hispanics (OR: 0.6; 95% CI: 0.4–0.9). Neuroimaging was
used less among patients with Medicare (OR: 0.4; 95% CI:
0.2–0.6) or Medicaid (OR: 0.5; 95% CI: 0.4–0.7) vs private
insurance and less in proprietary hospitals. Hospital
admission was less likely for Blacks vs Whites (OR: 0.6;
95% CI: 0.4–0.8).
Conclusion Seizures account for 1% of ED visits (1 million
annually). Seizure accounts for higher proportions of ED
visits among infants and toddlers, males and Blacks. Racial/
ethnic disparities in neuroimaging and hospital admission
merit further investigation.
Keywords Seizures.Emergencies.Emergencytreatment.
Ethnicgroups.Vulnerablepopulations.Racial/ethnic
disparities.Neuroimaging
Introduction
Although seizures are very common, with 11% of all
people having a seizure at some point in life, epilepsy
occurs in only 3% of the population [6, 11]. Thus, most
people who have a seizure do not have epilepsy, but rather
symptomatic seizures, defined as those caused by well-
defined acute insults. These patients are often cared for by
non-neurologists, in diverse settings including emergency
departments (EDs) and hospital wards.
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Boston, MA, USAThe epidemiology of epilepsy is well developed, but the
epidemiology of acute symptomatic seizures is less so [4].
Most knowledge on the occurrence of seizures in the
emergency department (ED) setting is based on small
studies, with only two samples of more than 1,000 patients
published, these having limited generalizability [12, 20].
Descriptive epidemiology is important for at least three
reasons. First, knowledge of health care utilization is
essential for planning and management. Second, descriptive
studies identify patient characteristics that constitute possi-
ble risk factors for disease, which can then be examined in
prospective studies. Finally, recent decades have seen the
emergence of literature documenting racial/ethnic dispar-
ities in care, and descriptive studies are crucial to identify
and monitor such disparities [21, 27]. Disparities are known
to exist in the treatment of epilepsy, but little is known
about racial/ethnic determinants of care for acute symp-
tomatic seizures [28].
This investigation was designed to: (1) define the
incidence and epidemiology of seizure presentations to
US EDs, in order to provide the basic descriptive
information that is necessary for understanding health care
utilization and planning future studies; (2) describe demo-
graphic features associated with presentation and disposi-
tion; and (3) examine whether ED care may be influenced
by race, ethnicity or insurance status.
In order to develop a broadly representative sample, we
combined 11 years of National Hospital Ambulatory
Medical Care Survey (NHAMCS) data, from 1993 to
2003 [18]. Based on information from small regional
studies, we hypothesized that there would be increased
rates of seizure among children in the febrile seizure age
range of 6 months to 6 years, males, and possibly Black
patients [4, 13, 22, 24, 25, 29, 30]. In addition, we
hypothesized that alcohol use and insurance status would
be associated with ED utilization for seizures, and that
likelihood of neuroimaging and hospital admission would
differ according to race, ethnicity and insurance status [20].
Methods
NHAMCS is a systematic sample of visits to EDs of
general and short stay hospitals, excluding federal, military
and Veterans Affairs hospitals in the 50 United States and
the District of Columbia. Its methods have been described
in detail, including the reciprocal inflation procedures used
to generate national estimates from the sample [17, 18].
Trained staff collect data using standardized forms during
randomly assigned 4-week periods. All collected forms are
sent to the Constella Group (Durham, NC, USA) and coded
using the International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM). Medications
are coded according to the National Drug Code Database
and include those administered in the ED or prescribed at
discharge [16].
Certain core variables are included in data collection
every year (such as demographic characteristics, up to three
diagnoses per visit and insurance status). Other variables
are collected only during some of the study years, including
diagnostic and surgical procedures including lumbar punc-
ture and electroencephalography. The present investigation
constitutes a retrospective analysis of this multi-year
database, without opportunity to influence what variables
were collected. Of note, tracking of chronic conditions such
as epilepsy is not within the scope of the NHAMCS as
information from the past medical history is not included in
the data form. It is not possible to quantify the proportion of
ED seizure patients who had pre-existing epilepsy using our
data source; nor could we differentiate a first-time seizure
from a recurrent seizure.
We assessed the frequency of visits for seizures by
identifying visits with ICD-9 codes 345 (epileptic con-
vulsions), 780.3 [convulsions: not otherwise specified
(NOS), febrile, or infantile; fit NOS] and 779.0 (convul-
sions in newborn) in any one of the three diagnosis fields.
The NHAMCS database does not differentiate patients
whose seizures had resolved upon ED arrival from patients
who continued to seize in the ED. US visit rates were
computed using mid-year age, sex, race, ethnicity, region
and metropolitan status-specific population estimates from
the US Census Bureau; all rates were reported per 1,000
individuals in the US resident population per year [1].
We analysed relationships between seizure visit rates,
sociodemographic variables, diagnoses other than seizure,
performance of neuroimaging, medications prescribed and
disposition. We included the following variables in multi-
variate analyses: urgency at triage, age, sex, race, Hispanic
ethnicity, insurance status, metropolitan statistical area
(MSA) status of the hospital (i.e. metropolitan vs not
metropolitan), hospital ownership category, region (North-
east, Midwest, South and West), presence of a “high-risk”
co-diagnosis, whether neuroimaging was performed and
ED disposition.
Regarding the coding of urgency at triage, from 1993 to
1996, visits were coded as urgent at triage yes/no. This
variable was not collected between 1997 and 2003. To keep
analyses between earlier and later years consistent, we
coded visits that occurred after a change in coding in 1997
(1997–2003) as “urgent/emergent” if immediacy to be seen
was recorded as “less than 15 min” or “15–60 min” and as
“non-urgent” if recorded as “>1–2 h or longer”.
Regarding neuroimaging, our analyses focused on
whether neuroimaging was performed at all. Data on
computed tomography (CT) scanning were collected alone
for years 1995–2000 and magnetic resonance imaging
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MRI were collected as “CT or MRI” and no longer
collected separately. We created a new variable for use of
either MRI or CT using years 1995–2003 and only analysed
1995–2003 data when evaluating neuroimaging. Thus the
fact that these data were included differently in the different
years of study had the effect of lowering power for analyses
of neuroimaging, but would not be expected to introduce
bias.
For the medication analysis, up to five medications
were recorded during 1993–1994, up to six between 1995
and 2002 and up to eight for 2003, with medications
coded as per published National Center for Health
Statistics (NCHS) definitions [16]. Medications recorded
included medications administered in the ED or prescribed
upon discharge.
To evaluate other diagnoses recorded among patients
with seizure (“co-diagnoses”), we focused on those that
were seen in ten or more of the visits in our sample. Using
ICD-9 codes, we identified 58 such diagnoses. For the
purpose of analytic control in our examination of demo-
graphic predictors of making a visit for seizure, receiving
neuroimaging services and being admitted to the hospital,
we created a binary variable to differentiate cases with and
without a “high-risk” co-diagnosis. We designated a co-
diagnosis “high risk” if, in our judgment, it would tend to
change ED management or warrant hospital admission.
Thus we categorized the following co-diagnoses as “high
risk”: alcohol withdrawal, pneumonia, cerebrovascular
disease, hypoglycaemia, septicaemia, hypokalaemia, tran-
sient ischaemic attack (TIA), hyponatraemia, brain neo-
plasm and intracranial injury. We identified alcohol-related
visits by ICD-9 codes and by a check box indicating a role
for alcohol, present during some of the years of study.
We performed all analyses using STATA 9.0 (StataCorp,
College Station, TX, USA). Information from a masked
sample design was used to estimate variance and calculate
95% confidence intervals (CI). Associations were examined
using Pearson’s chi-square. Linear regression was used for
trend analysis and multivariate logistic regression was used
to examine factors associated with seizure visit, neuro-
imaging and hospital admission. Multivariate models were
built, and potential confounding variables chosen, based on
a priori hypotheses, with one exception: in contemplating
our observation of racial and ethnic disparities in neuro-
imaging and hospital admission, we recognized that not
only “high-risk” diagnoses but also “low-risk” diagnoses
could have confounded our findings. In particular, if Black
and Hispanic children were more likely than other groups to
visit the ED after a febrile seizure, the likelihood of
neuroimaging and hospital admission would appear lower
in these groups. We were not overly concerned about this
possibility because our models control for insurance status.
Nonetheless, to be safe, in a post hoc analysis, we created a
variable to capture “low-risk” diagnoses, chosen from
among the diagnoses seen in >30 cases. A patient was
noted to have a “low-risk” diagnosis if s/he had otitis
media, acute respiratory infection or urinary tract infection.
Addition of this variable to the models resulted in no
change, and therefore we did not include it in the final
models.
All p values were two-tailed, with p<0.05 considered
statistically significant. If the relative standard error for
the NHAMCS data was greater than 30%, or if estimates
were based on fewer than 30 cases, confidence intervals
were not reported, since the estimates would not be robust.
Our human subjects research committee exempted the
study from review.
Results
From 1993 through 2003, there were a total of 1.1 billion
visits to US EDs, for an annual average of 100.7 million
visits per year. Seizure was present at 1.0% (95% CI: 0.9–
1.1%) of these visits, an average of 1 million per year (95%
CI: 926,000–1,104,000), with no change in seizure fre-
quency over the 11-year study period (p for trend 0.20).
These estimates are based on a sample of 341,000 ED visits
for all ages, of which 3,215 involved seizure. On a
population basis, there were 3.7 (95% CI: 3.4–4.0) ED
visits for seizure per 1,000 US residents per year.
For children (age <18), there were 293 million total
visits to US EDs, for an annual average of 27 million per
year. Of these, 3.1 million visits involved seizure (95% CI:
2.7–3.5 million) which corresponded to 1.0% (95% CI:
0.9–1.2) of all ED visits for children. On a population basis,
there were 4 ED visits (95% CI: 3.5–4.4) for seizure per
1,000 US residents aged <18 per year.
Table 1 provides the distribution of ED seizure visits by
patient and hospital characteristics. Frequency of seizure
visits did not differ significantly across any time of day, day
of the week, season or year of visit (data not shown).
Figure 1 depicts the age dependence of ED utilization for
seizure, showing annual estimates based on our 11 years of
data. It was necessary to stratify children as shown because
the epidemiology of the febrile seizure is an important sub-
topic. However, we could not create an age stratum for 6
months to 6 years (corresponding to the defining ages of the
febrile seizure), because monthly age data were not usable.
On a population basis, ED visits for seizure were
significantly more common among infants and children
aged 1–5 years (approximating the age of the febrile
seizure) and the 41–50 year group than among other age
groups. Adolescents and the elderly made the fewest visits
for seizure on a population basis.
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aged 41–50, we sought to determine whether alcohol
played a role in determining the proportion of ED visits
with seizure, by excluding all visits with mention of alcohol
(6.4% of all visits). In the 41–50 age group, as a result of
this adjustment, the proportion decreased from 1.4 to 1.2%
(95% CI: 1.0–1.4%).
Table 1 shows results by gender, race and insurance
status. In a multivariate logistic regression (controlling for
age, ethnicity, region, metropolitan status and insurance
status), Table 3 factors significantly associated with a
higher proportion of seizure visits among all ED visits
included male gender [odds ratio (OR): 1.4], Black race
(OR: 1.4) and alcohol-related visit (OR: 3.2).
At least one co-diagnosis was noted in 66% of cases.
There were over 500 different co-diagnoses, and each of
these tended to be noted in only a few cases, prohibiting
estimation of national totals. Only 9 co-diagnoses were
reported in 30 or more cases; see Table 2. Among these,
alcohol-related issues were most common. Otitis media was
second most common, perhaps as a cause of febrile
seizures. “High risk” associated diagnoses (as defined in
the “Methods” section) were present in 7.1%; the most
prevalent of these was pneumonia, seen in 1.2% of all ED
seizure visits. Injuries were less commonly seen in patients
with seizures than in non-seizure patients (17.9 vs 34.7%,
p<0.001). Meningitis and tricyclic antidepressant poisoning
were seen in too few cases for robust national estimates.
Blood glucose checks were documented in 31% of visits,
but results from glucose analysis in the prehospital and
laboratory settings were not recorded.
At least one medication was noted at 78% of visits;
Table 2 shows the ten most common. A benzodiazepine or
a barbiturate was prescribed at 54.0% (95% CI: 51.8–56.3)
Table 1 Distribution of emer-
gency department seizure visits
in the USA by patient and
hospital characteristics
(1993–2003)
ED emergency department, CI
confidence interval, MSA met-
ropolitan statistical area
a“Other race” includes Asian,
Pacific Islander, American In-
dian or more than one race was
reported
b19% of sample missing eth-
nicity data
Group Sample
(n)
Cumulative estimate
in thousands (95% CI)
Annual average rate
per 1,000 US
population (95% CI)
Annual average rate
per 1,000 ED visits
(95% CI)
Overall 3,215 11,200 (10,200–12,100) 3.7 (3.4–4.0) 10.1 (9.2–10.9)
Age (years)
<1 106 348 (260–437) 8.0 (6.0–10.1) 8.5 (6.3–10.6)
1–5 450 1,613 (1,402–1,824) 7.4 (6.4–8.4) 15.1 (13.1–17.0)
6–10 121 456 (338–575) 2.1 (1.5–2.6) 8.1 (6.0–10.2)
11–15 101 374 (277–472) 1.7 (1.3–2.2) 6.5 (4.8–8.2)
16–20 197 775 (606–944) 3.6 (2.8–4.4) 8.9 (7.0–10.8)
21–30 436 1,497 (1,266–1,727) 3.6 (3.0–4.1) 8.1 (6.9–9.4)
31–40 552 1,880 (1,653–2,107) 3.9 (3.4–4.4) 11.1 (9.7–12.4)
41–50 564 1,848 (1,607–2,090) 4.2 (3.7–4.8) 14.2 (12.4–16.1)
51–60 249 846 (699–994) 2.8 (2.3–3.3) 10.1 (8.3–11.8)
61–70 177 610 (479–741) 2.8 (2.2–3.4) 9.1 (7.2–11.1)
71–80 155 526 (417–634) 3.2 (2.5–3.8) 7.6 (6.1–9.2)
81+ 107 393 (266–520) 0.4 (0.3–0.5) 7.1 (4.8–9.4)
<18 850 3,095 (2,726–3,463) 4.0 (3.5–4.4) 10.6 (9.3–11.8)
≥18 2,365 8,073 (7,325–8,821) 3.6 (3.3–3.9) 9.9 (9.0–10.8)
Sex
Female 1,395 4,844 (4,358–5,331) 3.2 (2.8–3.5) 8.3 (7.4–9.1)
Male 1,820 6,323 (5,731–6,915) 4.3 (3.9–4.7) 12.1 (11.0–13.2)
Race
White 2,186 7,827 (7,055–8,600) 3.2 (2.9–3.5) 9.3 (8.3–10.2)
Black 910 2,995 (2,586–3,403) 7.9 (6.8–8.9) 12.9 (11.1–14.6)
Other
a 119 345 (260–431) 2.2 (1.6–2.7) 11.6 (8.7–14.5)
Ethnicity
b
Hispanic 348 1,085 (871–1,299) 3.1 (2.5–3.7) 11.4 (9.2–13.7)
Non-Hispanic 2,381 8,282 (7,503–9,062) 3.1 (2.8–3.4) 11.8 (10.7–12.9)
Urban status
MSA 2,844 9,231 (8,249–10,200) 3.8 (3.4–4.2) 10.6 (9.5–11.8)
Non-MSA 371 1,937 (1,296–2,577) 3.1 (2.1–4.2) 8.1 (5.4–10.7)
US region
Northeast 801 2,193 (1,847–2,538) 3.8 (3.2–4.4) 10.1 (8.5–11.6)
Midwest 638 2,619 (2,132–3,106) 3.8 (3.1–4.5) 9.3 (7.6–11.0)
South 1,076 4,145 (3,478–4,811) 3.9 (3.3–4.5) 10.1 (8.5–11.8)
West 700 2,211 (1,818–2,604) 3.3 (2.7–3.9) 11.1 (9.1–13.1)
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1.1% (95% CI: 0.6 - 1.7%) of ED seizure visits.
Neuroimaging (CT or MRI) was noted in 24% of seizure
visits (Table 2). Table 3 gives the results of a multivariate
logistic regression analysis designed to determine predictors
of neuroimaging. The regression model controlled for age,
sex, race, ethnicity, hospital ownership category, region,
MSA status, payer, urgency at triage, alcohol, “high risk”
associated diagnosis and hospital admission. Older age was
a significant predictor of higher likelihood of neuroimag-
ing, with each successive age category 1.2 times as likely to
receive neuroimaging on average. Despite control for
insurance status, Blacks were less likely to receive neuro-
imaging than Whites (OR: 0.6). Hispanics were less likely
to receive neuroimaging than non-Hispanics (OR: 0.6).
Relative to patients with private insurance, those with
Medicare were less likely to receive neuroimaging (OR:
0.4), and those with Medicaid were also less likely to
receive neuroimaging (OR: 0.5). Self-pay patients were no
less likely to receive neuroimaging than those with private
insurance. Visits by Medicare patients aged 65 or older had
a relatively high rate of neuroimaging (34%), and those by
Medicare patients aged <65 had a relatively low rate (19%).
Regarding disposition, none of the patients with seizure
in our sample died in the ED. Hospital admission was the
endpoint of 23% of seizure visits, versus 13% for non-
seizure visits (p<0.001). Table 3 gives the results of a
multivariate logistic regression analysis designed to deter-
mine predictors of hospital admission. The regression
model controlled for age, sex, race, hospital ownership,
ethnicity, hospital status, region, MSA status, payer,
urgency at triage, alcohol, “high risk” associated diagnosis
and whether neuroimaging was performed. Factors associ-
Table 2 Co-diagnoses, diagnostic tests and medications among US
emergency department patients with seizure (1993–2003)
Group Sample
(n)
% (95% confidence
interval)
Co-diagnoses
Alcohol-related 224 6.4 (5.3–7.6)
Otitis media (unspecified) 103 3.4 (2.6–4.3)
Hypertension (unspecified) 59 1.4 (0.9–1.8)
Acute respiratory infection 38 1.4 (0.9–1.9)
Pneumonia 35 1.2 (0.7–1.7)
Urinary tract infection 35 1.2 (0.7–1.7)
Cerebrovascular disease 32 0.8 (0.4–1.2)
All high-risk co-diagnoses
a 217 7.1 (5.9–8.4)
Diagnostic tests
Neuroimaging (CT or MRI)
b 626 24.2 (22.1–26.3)
Lumbar puncture
c 44 2.3 (1.5–3.1)
EEG 51 4.0 (2.4–5.5)
Glucose screen
c 402 31.3 (27.4–35.3)
Top ten medications
Phenytoin 1003 29.9 (27.8–32.0)
Acetaminophen 435 13.0 (11.5–14.6)
Lorazepam 351 10.5 (9.1–11.8)
Ibuprofen 252 7.9 (6.6–9.1)
Phenobarbital 247 7.4 (6.1–8.7)
Carbamazepine 244 7.8 (6.6–9.0)
Diazepam 185 6.1 (5.0–7.1)
Divalproex sodium 154 4.7 (3.7–5.7)
Ceftriaxone 130 4.2 (3.2–5.2)
Thiamine 101 2.8 (2.2–3.5)
aIncludes alcohol withdrawal, pneumonia, cerebrovascular disease,
hypoglycaemia, septicaemia, hypokalaemia, TIA, hyponatraemia,
brain neoplasm and intracranial injury
bData not available for 1993–1994
cData not available for 2001–2003
Fig. 1 Annual population rates for US emergency department visits for seizure (1993–2003)
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age, urgency at triage, “high-risk” diagnosis as defined
above and having received neuroimaging. Blacks were less
likely to be admitted than Whites (OR: 0.6). There was no
relationship between hospital admission and Hispanic
ethnicity or insurance status.
Discussion
We estimate that seizures account for 1 million ED visits
per year, or 1% of all ED visits, in the US. This is
consistent with the findings of three smaller studies that
reported the frequency of seizures among general ED visits
to be 0.7–1.2% [13, 14, 24]. In our study, among children,
1% of ED visits involved seizure. Only one prior study
reported the proportion of children’s ED visits due to
seizure (2%), but that study was done at a tertiary referral
centre whose population is not representative of that seen in
most EDs [26].
On a population basis, the rate of ED visits for seizure
was 3.7 per 1,000 population per year. ED visits with
seizure were most common among infants, at a rate of 8.0,
and children aged 1–5 years, at 7.4. Possible explanations
for this high rate of seizure visits include electrolyte
abnormalities and febrile seizures [2, 8, 9, 23]. Another
possibility is that some of the infants whose diagnosis was
coded as seizure may actually have had other conditions,
such as myoclonus or other unusual movements that worry
parents. No prior study has reported the population rates of
ED visits for seizure. One study examined the incidence of
acute symptomatic seizures in an entire population, finding
39 seizures per 100,000 person-years of observation [4].
This is not comparable to our findings as it excluded all
unprovoked seizures and all febrile seizures. Moreover, that
study involved the population of Rochester, MN, one that
may not be representative of that served by the nation’s
EDs.
Our data revealed a peak in ED utilization for seizure
among middle-aged patients. Seizure accounted for a
significantly higher proportion of ED visits in this age
group than in any other group except for children aged 1–5
years. This was not entirely explained by correlation with
alcohol-related diagnoses. In contrast, the population-based
study mentioned above found a steady increase in the
population incidence of acute symptomatic seizures among
adults, with no peak in middle age, from 15 per 100,000
patient-years of observation among those aged 25–34 to 44
among those aged 45–54 and 123 among those aged >74
years [4]. This is likely because, when compared to the
general population of middle-aged adults, those seen in the
ED are more at risk for seizure due to influences such as
alcohol abuse, trauma and chronic illness, and middle-aged
adults may be less likely to use the ED for non-seizure
problems than other age groups.
We confirmed our hypothesis that seizures account for a
higher proportion of ED visits among males than among
females. However, the disparity was not as pronounced as
initially expected. Prior studies found that males accounted
for nearly twice as many ED visits for seizures [4, 12, 13,
20, 24, 25, 29]. Our study found that males were 1.4 times
as likely as females to have a seizure-related ED visit. This
could indicate that females with seizure are more likely to
seek ED care in general, or that the increased incidence
among males is truly not as high as prior studies have
suggested.
Table 3 Controlled multivariate analysis to predict neuroimaging and
hospital admission among emergency department patients with seizure
(1993–2003)
Group Likelihood of
neuroimaging
Likelihood of
hospital admission
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Age (per decade) 1.2 (1.2–1.3)
a 1.2 (1.1–1.3)
a
Sex
Male (vs female) 1.0 (0.8–1.4) 1.0 (0.8–1.3)
Race
Black (vs White) 0.6 (0.4–0.8)
a 0.6 (0.4–0.8)
a
Other (vs White) 0.7 (0.3–1.7) 1.3 (0.5–3.1)
Ethnicity
Hispanic (vs non-Hispanic) 0.6 (0.4–0.9)
a 1.4 (0.8–2.3)
Urban status
MSA (vs non-MSA) 2.0 (1.2–3.1)
a 1.3 (0.8–2.0)
US region
Northeast 1.0 1.0
Midwest 1.9 (1.2–2.8)
a 1.1 (0.7–1.8)
South 2.0 (1.3–3.0)
a 0.9 (0.6–1.4)
West 1.9 (1.2–2.9)
a 0.5 (0.3–0.8)
a
Hospital ownership
Voluntary (non-profit) 1.0 1.0
Government non-federal 0.8 (0.5–1.2) 0.9 (0.5–1.4)
Proprietary 0.6 (0.4–0.97)
a 0.8 (0.5–1.3)
Insurance status
Private insurance 1.0 1.0
Medicare 0.4 (0.2–0.6)
a 1.3 (0.8–2.2)
Medicaid 0.5 (0.4–0.7)
a 1.0 (0.7–1.6)
Self-pay 0.9 (0.6–1.4) 0.7 (0.4–1.1)
Other insurance 0.5 (0.3–0.9)
a 0.8 (0.4–1.4)
Urgency at triage 1.7 (1.0–2.9)
a 2.3 (1.3–3.9)
a
Alcohol-related visit 0.7 (0.4–1.3) 1.5 (0.8–2.9)
High-risk co-diagnosis 1.8 (1.0–3.1)
a 2.5 (1.4–4.5)
a
CT or MRI Outcome variable 3.2 (2.3–4.4)
a
Hospital admission 3.1 (2.2–4.4)
a Outcome variable
MSA metropolitan statistical area, CT computed tomography, MRI
magnetic resonance imaging
aStatistically significant at α=0.05
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thanamongWhites.Thisisanewfinding,exceptforoneprior
study that noted slightly increased ED utilization for seizure
among Blacks, but relied upon historical controls rather than
population data (i.e. the US Census) for a description of the
sourcepopulation,anddidnotcontrolforinsurancestatus[20,
28]. As predicted, we found that the prominence of seizure
among ED visits was higher among those with public
insurance, relative to those with private insurance.
We observed racial and ethnic disparities in neuro-
imaging of ED patients with seizure. Neuroimaging was
performed at 24% of all seizure visits, but Blacks and
Hispanics were significantly less likely to receive neuro-
imaging than their White and non-Hispanic counterparts.
This finding was robust to analytic control for age, gender,
hospital ownership, insurance, region, urgency at triage,
alcohol, “high risk” associated diagnosis and hospital
admission. This is not likely to be solely a factor of
differential rates of known seizure disorder, as only a
minority of ED seizure visits are due to a known seizure
disorder [12, 20]. For Hispanics, this pattern is the opposite
of what has been found for neuroimaging in patients with
cerebrovascular disease. One study showed higher utiliza-
tion among Hispanics compared to Whites, possibly due to
language barriers leading to reliance on testing in place of
history [7]. The reasons for differential neuroimaging
according to race/ethnicity may be different among patients
with seizure versus cerebrovascular disease. As the
NHAMCS database does not contain details of the
presentation or physical exam, it is not possible to
determine the “appropriate” rate of neuroimaging according
to national guidelines in place at the time. In fact, while
some suggest that neuroimaging may be overused [3, 9] the
most recent expert guidelines offer few restrictions, finding
that acute neuroimaging may be useful in adults or children
with first seizure, with acquired immunodeficiency syn-
drome (AIDS), an abnormal neurologic exam, worrisome
history or focal seizure onset [10, 15]. Therefore, our
finding of less neuroimaging among minorities resonates
with the findings of racial and ethnic disparities in
diagnostic procedures in many prior studies [27]a n d
highlights the need for future work to address potential
disparities in health care delivery [28].
Interestingly, neuroimaging was substantially less com-
mon in proprietary hospitals than in non-profit and non-
federal government hospitals. Whether this was due to
differing patient characteristics or economic influences
could not be ascertained in this study.
We observed an overall admission rate of 23%, identical
to the rate seen in a prior multicentre study of 368
unselected seizure patients [13]. Our finding of a lower
likelihood of hospital admission among Black ED patients
with seizure is difficult to explain.
Racial and ethnic disparities in health care have been
documented in a variety of settings, including in the
outpatient management of epilepsy [28], but to our
knowledge this is the first report of disparities in the
emergency care of patients with seizure. The reason for the
disparities we observed cannot be ascertained from our
source data, but the adjustment for geographic region,
hospital characteristics and insurance status rules out
several factors often cited as potential explanations for
racial/ethnic disparities [5]. Other possibilities include
hospital-level variation in key variables such as ED
crowding and availability of neuroimaging, socioeconomic
or biological determinants of different aetiologies for
seizure among different groups or subconscious bias on
the part of health care providers [27, 31]. Increased use of
the ED for low-acuity problems predisposing to febrile
seizure, such as otitis media, is not a plausible explanation
for our findings, because: (a) seizure is certainly not a
“primary care” type of complaint and (b) inclusion of “any
low-risk diagnosis” in our controlled models did not change
the findings (see “Methods” section). If alcohol played a
role in minorities more frequently than in Whites, both
neuroimaging and hospital admission would have been
indicated less frequently for minority patients. However,
our analysis controlled for alcohol-related visits, and for
socioeconomic marginalization as indicated by insurance
status. Nonetheless, since this is a secondary data analysis,
the robustness of such control cannot be trusted absolutely.
Thus it remains possible that socioeconomically disadvan-
taged groups might have been more likely to use the ED for
alcohol-related seizures.
Insurance status was a significant predictor of neuro-
imaging, but not hospital admission. Medicare and Medicaid
patients were significantly less likely to have neuroimaging
than patients with private insurance. Medicare patients likely
had a low rate of neuroimaging because many patients have
Medicare not due to old age, but due to chronic illness. A
high rate of unprovoked seizures due to previously diag-
nosed seizure disorders would lead to many ED visits for
seizure without neuroimaging in this group. Indeed, we
found that Medicare patients below age 65 had a very low
rate of neuroimaging (19%).
Our study has certain limitations. Because NHAMCS
data only contain information about the ED visit itself,
actions taken before arrival to the ED or after discharge or
hospital admission are not available for analysis. The
NHAMCS is not designed to collect information about
chronic conditions, and thus we were unable to ascertain
what proportion of our cases were “breakthrough seizures”
occurring in patients who already had a diagnosis of
epilepsy, versus acute symptomatic seizures, versus first-
time unprovoked seizures. Repeat visits are unlikely to
have been a major factor, as individual EDs were sampled
Int J Emerg Med (2008) 1:97–105 103only for 4-week periods. Nonetheless, the discrepancies in
neuroimaging we observed should be verified in a study of
identified cases to remove the unlikely possibility of
confounding by repeat visits. Data on Hispanic ethnicity
were missing in 19% of our sample. Finally, limitations in
the use of ICD-9 coding have been described, and
therefore, the accuracy of various co-diagnoses, including
electrolyte disturbances and contribution of alcohol, is
difficult to ascertain [19]. The NHAMCS database is useful
for describing the demographic covariates of a straightfor-
ward diagnosis like seizure that is unlikely to go unmen-
tioned in an ED chart, but inferences about causal
relationships among seizure and other co-diagnoses would
not be appropriate.
Conclusion
In a nationally representative sample of seizure visits to US
EDs, we found that 1 million such visits occur each year,
with an admission rate of 23%. ED utilization for seizure
has a bimodal age distribution, with peaks in the first 5
years of life and in middle age, and is more common in
males. Among seizure patients seen in US EDs, neuro-
imaging services are used more in patients with private
insurance, and less among Blacks and Hispanics compared
to their White and non-Hispanic counterparts. Hospital
admission is also substantially less likely for Blacks than
for Whites. These disparities were not explained by
alcohol-related seizures in the present secondary data
analysis, but future studies should examine this potential
confounder. These observations were robust to analytic
control for multiple potential confounders including age,
sex, insurance status, geography and hospital ownership.
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